AimwellBio publishes investor briefing on $10m acquired IP portfolio
AimwellBio (AIMN) publishes an investor briefing on an acquired Trustr intellectual property portfolio valued at $10m, emphasizing transparency.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.